Coya Therapeutics, Inc. — All Filings
210 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
4
4/A
424B3
424B4
424B5
424B7
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| UPLOAD | — | 0000000000-22-012032 | Nov 4, 2022 | — |
| DRSLTR | — | 0000950123-22-010566 | Oct 28, 2022 | — |
| DRS/A | — | 0000950123-22-010565 | Oct 28, 2022 | — |
| UPLOAD | — | 0000000000-22-011498 | Oct 19, 2022 | — |
| DRSLTR | — | 0000950123-22-010098 | Oct 7, 2022 | — |
| DRS/A | — | 0000950123-22-010095 | Oct 7, 2022 | — |
| UPLOAD | — | 0000000000-22-010127 | Sep 15, 2022 | — |
| DRS | — | 0001564590-22-029826 | Aug 19, 2022 | — |
| D | — | 0001493152-22-014555 | May 20, 2022 | — |
| D | — | 0001835022-21-000001 | Jan 5, 2021 | — |